Financial Enhancement Group LLC Gilead Sciences, Inc. Transaction History

Financial Enhancement Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1,699 - $1,936	-30 Closed	0 $0
Q3 2020 Nov 18, 2020	BUY	$62.1 - $78.08 $1,863 - $2,342	30 New	30 $2,000
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $31,182 - $34,967	-504 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $31,515 - $35,305	504 New	504 $33,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.